Search Results for 'macular degeneration'
-
Ocutrx Unveils ORLenz for Surgery Visualization Technology in ARWear Headset
The Oculenz AR Wear headset now provides the technology surgeons have been missing for use during medical procedures.Ocutrx Vision Technologies LLC 11.20.19
-
Study Shows Real-World Significance of EyeArt AI Eye Screening System From Eyenuk
Data validates the prowess of the EyeArt AI System for diabetic retinopathy screening.Business Wire 10.02.19
-
European Approval Given to Altris AI Algorithm for Retinal Conditions Detection
Altris AI diagnostic software is based on computer vision and deep learning technologies which automatically analyzes OCT images.Business Wire 09.24.19
-
Pre-Pilot Trial From Ocutrx Vision Technologies Yields Promising Results for Patients With AMD
New Oculenz headset enhances functional vision for patients with severe age-related macular degeneration.Ocutrx Vision Technologies 08.02.19
-
Contract Manufacturing
Glaukos Corporation to Acquire DOSE Medical Corporation
DOSE Medical will become a wholly owned subsidiary of Glaukos.Business Wire 06.20.19
-
Implanted Drug ‘Reservoir’ Safely Reduces Injections for Macular Degeneration Patients
Implanting a medication reservoir in eyes lessens the need for injections and may reduce clinic visits to twice per year.Johns Hopkins Medicine 06.14.19
-
Eyenuk Combines AI Disease Detection and Human Grading to Launch Diabetic Retinopathy Diagnostic
The EyeScreen Service changes how healthcare providers screen for diabetic retinopathy.Business Wire 05.31.19
-
Ocutrx Vision Technologies Unveils Oculenz AR Cellular with Eye-Tracking Glasses Design
The glasses are low-profile and more lightweight than the HoloLens 2.Ocutrx Vision 04.09.19
-
Diagnostics
Notal Vision's Patient-Operated Home OCT System Granted Breakthrough Status
First-of-its-kind artificial intelligence-enabled technology for monitoring exudative age-related macular degeneration (AMD).PR Newswire 12.04.18
-
Researchers Develop New Devices to Test Retinal Cells
The aim is to better understand the triggers of age-related macular degeneration (AMD), a degenerative eye disease.Utah State University 10.25.18
-
Materials | Surgical
A New Generation of Artificial Retinas Based on 2D Materials
Few-layer graphene and molybdenum disulfide were used to successfully fabricate an artificial retina.American Chemical Society 08.20.18
-
Cardiovascular | Diagnostics | Patient Monitoring
FDA OKs Optovue's AngioAnalytics, the World’s First OCT Angiography Metrics
Aids in early detection and management of diseases causing progressive blindness.Business Wire 06.11.18
-
Cardiovascular | Digital Health | Neurological
-
Neurological
Lab-on-a-Chip Device Mimics Eye Damage Due to Intense Light
Houston Methodist researchers create eye neuron network model to study retinal diseases, possible treatment options.Houston Methodist 05.10.18
-
FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics
Actions part of a comprehensive approach to the oversight of regenerative medicine products.U.S. Food and Drug Administration 05.10.18
-
Neurological
Tiny, Light-Sensitive Chips Could Help Restore Sight to the Blind
Millions of people are slowly losing their vision to diseases of the retina, such as age-related macular degeneration.Nathan Collins, Stanford News Service 04.23.18
-
Eyenuk Inc. Receives Health Canada Approval for EyeArt
EyeArt screening software is designed to return results within 60 seconds and work with most fundus cameras.Business Wire 04.09.18
-
Surgical
Stem Cell-Based Retinal Implant Could Treat Common Cause of Vision Loss
Study was the first human trial of a novel stem cell-based therapy for advanced dry age-related macular degeneration.University of Southern California - Health Sciences 04.05.18
-
Pixium Vision Receives FDA Approval to Begin Human Clinical Study of Its PRIMA Sub-Retinal Implant
Study is designed to evaluate PRIMA in patients with Atrophic Dry Age-related Macular Degeneration.Business Wire 01.30.18
-
First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration
Telescope implant for end-stage macular degeneration is FDA approved and available to patients 65 years and older.Business Wire 10.13.17
-
Contract Manufacturing | R&D & Design | Software & IT
Oraya Therapeutics, OnCore Manufacturing Develop Macular Degeneration Treatment
First commercial IRay radiotherapy system will ship from U.S. to Europe.01.10.14
-
CMS OKs Payment for Implantable Miniature Telescope for Macular Degeneration
Device was approved by the FDA last year.09.08.11
